The NZX-50 had a flat day yesterday, barely halting its downward trend which kicked off on May 13 - just days after the listing of Mighty River Power.

Ebos Group's $1.1 billion acquisition of Australian firm Symbion this week again highlighted an ongoing issue with getting independent research on NZX-listed companies.

Ryman Healthcare's share price is making some in the market feel nervous that it is hitting bubble territory.

Local market players were feeling very nervous about Mighty River Power's share price on Tuesday...

Local market players believe the $2.50 per share price for Mighty River Power is a pretty good result...

The political machinations around the electricity sector have definitely added an element of higher risk to the Mighty River Power float making it even harder for retail investors to make a call on buying into the soon-to-be-listed power company.

The proof will be in the pudding for the Government next week as the Mighty River Power share offer officially opens to the public on Monday. It's hard to know how many of the 440,000 people who pre-registered will buy shares.

Looks like details of the long-awaited Mighty River Power float are set to be released on Monday with the Government raring to go after receiving the all clear from the Supreme Court.

The Reserve Bank is grappling with the prospect of a property bubble emerging from the current low interest rate environment.

Accountancy software firm Xero yesterday joined a short list of New Zealand companies to dual list in Australia.